Massachusetts Financial Services CO Co Diagnostics, Inc. Transaction History
Massachusetts Financial Services CO
- $321 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding CODX
# of Institutions
46Shares Held
4.23MCall Options Held
22.9KPut Options Held
30.4K-
Vanguard Group Inc Valley Forge, PA1.78MShares$2.21 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny600KShares$744,4960.0% of portfolio
-
Black Rock Inc. New York, NY500KShares$620,0620.0% of portfolio
-
Geode Capital Management, LLC Boston, MA294KShares$365,0830.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$338,3960.01% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $41.9M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...